This test is most useful if any of these apply to you.
Of all the places in your DNA linked to body weight, a stretch inside the FTO gene on chromosome 16 has shown the strongest and most consistent link in large genetic studies. This test reads one letter in that stretch, rs1421085. It is the letter researchers traced, in 2015, to a specific change in how fat cells handle energy.
It is also a very common variant. About 4 in 10 people worldwide, and about two in three people of European ancestry, carry at least one copy of the higher-risk version. Its effect is real but small: on average about 1 to 1.5 kg (2 to 3 pounds) of extra body weight per copy. Your daily habits, and treatment where it is needed, shape your weight far more than this one letter does.
Despite sitting inside FTO, the variant seems to act mainly on two neighboring genes, IRX3 and IRX5. In 2014, researchers showed that the obesity-linked region of FTO reaches across long distances of DNA to physically contact IRX3, and that obesity-linked variants there tracked with IRX3 activity, not FTO activity, in human brain tissue.
A 2015 study in the New England Journal of Medicine pinned this down to rs1421085. The common T letter is part of a docking site for ARID5B, a protein that acts as a brake on a genetic switch in young fat cells. The C letter breaks that docking site, the brake slips, and IRX3 and IRX5 become about twice as active as fat cells develop. In the lab, this pushed developing fat cells away from the beige type, which burns energy as heat, toward the white type, which stores it: heat production by the cells' mitochondria fell about fivefold and fat storage rose.
The researchers then used CRISPR gene editing to change the C back to T in fat cells from a person carrying the variant. The brake came back on, and heat production in those cells rose about sevenfold. That is strong evidence that rs1421085 itself is a cause, not just a marker sitting near one.
These experiments were done in cells and mice, so they show how the variant can change fat cells, not exactly how much of the weight difference in people comes from this route. Earlier research in people also pointed to subtle effects on food intake and food preference.
The FTO link was discovered in 2007, in a genome-wide search for type 2 diabetes genes that turned out to be picking up an effect on body weight. Across 13 groups totaling 38,759 people, adults with two copies of the higher-risk version weighed about 3 kg more and had 1.67 times the odds of obesity compared with people with none. The difference showed up from age 7 onward and reflected extra body fat specifically.
Later summaries put the average effect at about 0.39 BMI points, or roughly 1.1 kg, per copy, with about 20 percent higher odds of obesity per copy, and the effect tends to be largest in young adulthood. A meta-analysis of 218,166 adults found 23 percent higher odds of obesity per copy. In a European study of 2,900 people with early-onset or severe obesity and 5,100 people without it, the same stretch of FTO stood out strongly.
To put that in perspective, odds ratios like these describe a modest nudge across a whole population. Plenty of people with C/C stay at a healthy weight, and plenty with T/T do not. This result explains a small slice of your inherited tendency, not your weight.
Because extra body fat raises the chance of type 2 diabetes, the higher-risk FTO version is also linked to diabetes. In the first large European study, that link went away once BMI was taken into account. In a later meta-analysis of 96,551 East and South Asian adults, each copy raised the odds of type 2 diabetes by about 15 percent, similar to what was seen in Europeans, but about 10 percent remained after accounting for BMI, so in that study weight explained only part of the link. Researchers still debate whether FTO affects diabetes risk beyond its effect on weight.
What this means for you: the variant tilts the odds slightly. Your HbA1c and fasting glucose show whether your blood sugar is actually affected, and those numbers, not this genotype, guide decisions.
The most useful finding about FTO is that its effect is not fixed. In a meta-analysis of 45 studies and 218,166 adults, each copy of the higher-risk version raised the odds of obesity by 30 percent in physically inactive adults but by 22 percent in active adults, a 27 percent weaker genetic effect. The variant itself does not make people less active. The same softening was not seen in children and teenagers.
Weight-loss efforts also work just as well for carriers. A 2016 analysis pooled individual data from 9,563 overweight adults in eight randomized trials, mostly of diet and physical activity (one also tested two diabetes medicines). People with the higher-risk FTO version lost as much weight, BMI, and waist as everyone else. In the authors' words, the genetic tendency can be at least partly counteracted.
In the gnomAD v4.1 reference database, about 31 percent of all gene copies carry C. It is common in people of European ancestry (about 42 percent of gene copies), which works out to about two in three people carrying at least one copy and about 1 in 6 carrying two. It is highest in people of Ashkenazi Jewish ancestry (about 51 percent) and less common in people of South Asian (about 33 percent), Latin American (about 29 percent), East Asian (about 15 percent), and African ancestry (about 10 percent). Where it is less common, its effect per copy appears similar or somewhat smaller.
Most of the large studies on this page measured a neighboring FTO variant, rs9939609, or a close stand-in for it. Your report may describe the two as being in linkage disequilibrium, the geneticists' term for variants that tend to be inherited together. In people of European ancestry, rs1421085 and rs9939609 are inherited together almost every time, so the same estimates apply and the two results usually line up. In people of African ancestry, the rs9939609 risk letter is common (about half of gene copies) while C here is much rarer (about 1 in 10 or fewer). Someone with C here will usually carry the rs9939609 risk letter too, but many people carry that letter without C, so the two results often differ and each should be read on its own.
Your report shows the two letters at this position, one inherited from each parent, read on the forward strand of chromosome 16, the same strand the FTO gene is read from. T is the more common version and C is the higher-risk version. T/T means no copies, T/C or C/T means one copy (the order does not matter), and C/C means two. The report may also give the gene-level name, c.46-43098T>C, which describes the same change.
ClinVar, the US public database of variant classifications, lists rs1421085 as a risk factor for obesity. That label means a variant linked to a somewhat higher chance of a condition, not one that causes it on its own.
Your DNA does not change. Your rs1421085 genotype at 25 will be the same at 65, so there is no reason to repeat this test. What changes over time, and what is worth tracking, is your body composition, waist size, and blood sugar.
Whatever your genotype, the next steps are the same, and the evidence says they work just as well if you carry the variant:
Carrying the C version is common and nudges the odds, but it does not decide your weight. The habits you keep, and care when you need it, do far more.
FTO Genotype (rs1421085) is best interpreted alongside these tests.
FTO Genotype (rs1421085) is included in these pre-built panels.
Screens 140+ genes linked to inherited cholesterol disorders and other hidden drivers of heart disease risk.